PTC Therapeutics
PTCT
PTCT
115 hedge funds and large institutions have $310M invested in PTC Therapeutics in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $313M → $310M (-$2.68M)
9% less call options, than puts
Call options by funds: $15.1M | Put options by funds: $16.5M
7% less funds holding
Funds holding: 123 → 115 (-8)
Holders
115
Holding in Top 10
3
Calls
$15.1M
Puts
$16.5M
Top Buyers
| 1 | +$31.6M | |
| 2 | +$14.8M | |
| 3 | +$14.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$12.3M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$7.75M | |
| 3 | -$7.19M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$6.76M |
| 5 |
SA
Sicart Associates
New York
|
-$4.7M |